Unknown

Dataset Information

Feasibility and Safety of Diffusing Alpha-Emitter Radiation Therapy for Recurrent or Unresectable Skin Cancers.


ABSTRACT:

Importance

Patients with recurrent or unresectable skin cancers have limited treatment options. Diffusing alpha-emitter radiation therapy (DaRT), a novel solid tumor management strategy using alpha-particle interstitial brachytherapy, may address this challenge.

Objective

To evaluate the feasibility and safety of using DaRT to manage recurrent or unresectable skin cancers.

Design, setting, and participants

This prospective cohort study of patients who received a 2-week to 3-week treatment course and were followed up for 24 weeks after treatment during 2021 and 2022 at 2 sites in the US. Patients with malignant skin tumors or soft tissue tumors were recruited if they had limited treatment options for tumors recurrent after prior surgery or external beam radiotherapy or

SUBMITTER: D'Andrea MA 

PROVIDER: S-EPMC10176125 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature